Clinical Laserthermia Systems (CLS) is a Lund-based MedTech company developing TRANBERG, a minimally invasive laser-based cancer treatment system (LITT — Laser Interstitial Thermal Therapy). The technology enables precise, image-guided thermal ablation of tumors in organs including the brain, prostate, and liver. CLS raised $2M in November 2024 to advance its commercial rollout and clinical evidence generation for TRANBERG across European and US markets.
clinicallaserthermia.comPart of: Skåne Startup map